Great Lakes Advisors, LLC Seagen Inc. Transaction History

Great Lakes Advisors, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	SELL	$191.51 - $216.16 $3,064 - $3,458	-16 Reduced 0.75%	2,126 $451,000
Q2 2023 Aug 10, 2023	BUY	$187.64 - $206.25 $3,377 - $3,712	18 Added 0.85%	2,142 $412,000
Q1 2023 May 10, 2023	SELL	$127.59 - $203.08 $21,052 - $33,508	-165 Reduced 7.21%	2,124 $430,000
Q4 2022 Feb 09, 2023	SELL	$117.37 - $139.17 $15,140 - $17,952	-129 Reduced 5.33%	2,289 $294,000
Q3 2022 Nov 09, 2022	SELL	$135.27 - $180.11 $6,222 - $8,285	-46 Reduced 1.87%	2,418 $331,000
Q2 2022 Aug 09, 2022	SELL	$108.81 - $179.33 $19,476 - $32,100	-179 Reduced 6.77%	2,464 $436,000
Q1 2022 May 06, 2022	SELL	$119.61 - $157.85 $26,553 - $35,042	-222 Reduced 7.75%	2,643 $381,000
Q4 2021 Feb 09, 2022	SELL	$142.57 - $190.86 $29,226 - $39,126	-205 Reduced 6.68%	2,865 $443,000
Q3 2021 Nov 09, 2021	SELL	$142.45 - $169.82 $178,347 - $212,614	-1,252 Reduced 28.97%	3,070 $521,000
Q2 2021 Aug 11, 2021	SELL	$135.08 - $161.1 $48,493 - $57,834	-359 Reduced 7.67%	4,322 $682,000
Q1 2021 May 03, 2021	SELL	$137.51 - $190.8 $22,276 - $30,909	-162 Reduced 3.35%	4,681 $650,000
Q4 2020 Feb 09, 2021	BUY	$164.63 - $211.93 $797,303 - $1.03 Million	4,843 New	4,843 $848,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Great Lakes Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Great Lakes Advisors, LLC with notifications on news.